These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22010344)

  • 41. Chestnutamide: a novel alkaloid from flowers of Castanea mollissima Blume.
    Wang S; Ding XB; Chen YF; Yu DQ
    J Asian Nat Prod Res; 2001; 3(2):89-93. PubMed ID: 11407819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Research progress of especial toxicity and of pyrrolizidine alkaloids].
    Han J; Liang A; Gao S
    Zhongguo Zhong Yao Za Zhi; 2011 May; 36(10):1397-401. PubMed ID: 21837989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of the potential forensic significance of traditional herbal medicines.
    Byard RW
    J Forensic Sci; 2010 Jan; 55(1):89-92. PubMed ID: 20412155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Suggestion on standardizing clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia 2010 edition].
    Gao X; Zhang B; Zhong G; Zhang D
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2972-4. PubMed ID: 20209969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Patented technology status quo and development trend for Chinese herbal medicines].
    Li C; Huang L
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1468-72. PubMed ID: 19771885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.
    Xiong A; Shao Y; Fang L; Yang X; Zhang S; Zheng J; Ding W; Yang L; Wang Z
    Phytomedicine; 2019 Feb; 54():77-88. PubMed ID: 30668385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Key-point investigation list of traditional Chinese medicinal materials for national survey of Chinese material medica resources].
    Zhang XB; Guo LP; Zhang Y; Zhou LY; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1345-59. PubMed ID: 25039164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qianliguang (Senecio scandens) safety dilemma: dose is the key?
    Lin G; Li SL; Li M; Li N; Sun-Kin Chan S; Chan WY; Zhao ZZ
    Planta Med; 2009 Aug; 75(10):1107-11. PubMed ID: 19296428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Construction of biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wei L; Dong L; Zhu ML; Tang MM; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4479-83. PubMed ID: 25911786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality control of traditional Chinese medicines: a review.
    Song XY; Li YD; Shi YP; Jin L; Chen J
    Chin J Nat Med; 2013 Nov; 11(6):596-607. PubMed ID: 24345500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Probe into innovation and development of pattern of quality control and evaluation for Chinese medicine].
    Xiao XH; Jin C; Zhao ZZ; Xiao PG; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(14):1377-81. PubMed ID: 17966345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Status and problem analysis of drying process and equipment for traditional Chinese medicinal materials and preparations].
    Zhan JJ; Wu ZF; Wang YQ; Wu SQ; Wang XC; Yue PF; Yang M
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(23):4715-20. PubMed ID: 27141689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medicinal plants in China containing pyrrolizidine alkaloids.
    Roeder E
    Pharmazie; 2000 Oct; 55(10):711-26. PubMed ID: 11082830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Discovery strategy for effective and active constituents of Chinese material medica based on processes of metabolism and disposition in intra-body].
    Yang XW
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):365-70. PubMed ID: 17511134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The current global status of Chinese materia medica.
    Liu X; Zou J; Sheng Z; Su G; Chen S
    Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory Perspectives of Pyrrolizidine Alkaloid Contamination in Herbal Medicinal Products.
    Wiesner J
    Planta Med; 2022 Feb; 88(2):118-124. PubMed ID: 34169489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advance on pharmacologic actions, toxicity and pharmacokinetics of pyrrolizidine alkaloids].
    Gao J; Wang C; Li Y; Wang Z
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):506-11. PubMed ID: 19526771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hypothesis and establishment of 2-dimensional molecular marking method inidentification of Chinese material medica].
    Huang L; Wang X; Guo L; Shao A
    Zhongguo Zhong Yao Za Zhi; 2012 Apr; 37(8):1093-6. PubMed ID: 22779356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and Toxicity Evaluation of Pyrrolizidine Alkaloids in Medicinal Plants Gynura bicolor and Gynura divaricata Collected from Different Chinese Locations.
    Chen J; Lü H; Fang LX; Li WL; Verschaeve L; Wang ZT; De Kimpe N; Mangelinckx S
    Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27623358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.